NGM Biopharma Raises First Round

NGM Biopharmaceuticals Inc., a Hillsborough, Calif.-based drug startup focused on metabolic diseases, has raised $25.55 million in Series A funding, according to a regulatory filing. So far it had called down around $8.5 million. Backers include Column Group, Prospect Venture Partners and Rho Ventures.